Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer

Clinical trial NCT00868634 · COMPLETED

Trial details

NCT number: NCT00868634
Sponsor: iOMEDICO AG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2009-02-01
Primary completion: 2014-03-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.